Withholding the drug before surgery allows gastric motility to normalize and reduces the rate of both aspiration and pulmonary complications
By 3 to 6 months, many patients experience significant progress, with some achieving double-digit percentage weight loss depending on adherence and individual metabolic response
Kurtzhals, P., stergaard, S., Nishimura, E
Studies show people typically lose 10-15% of their body weight with semaglutide and 15-20% with tirzepatide over 6-18 months
Semaglutide GLP-1 is capable of controlling the appetite to a degree and reducing the amount of food that patients will want to consume in order to help them lose weight long-term while combined with diet and exercise
Metabolic Adaptation Is Kicking In